Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Go back to Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers| (NASDAQ: ORGO) | Delayed: 1.42 +0.06 (4.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.36 | 52 Week High | $ | |||
| Open | $1.36 | 52 Week Low | $ | |||
| Day High | $1.42 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 1,003,440 | |||||
